Trademarkia Logo

Australia

AU$
KATAMARYN
Accepted: In opposition period

Last updated on 4 Sept 2024

Owner Info

Boston Pharmaceuticals, Inc.

55 Cambridge Parkway, Suite 401

Cambridge MA 02142, UNITED STATES OF AMERICA

Serial Number

2447216 filed on 21 Mar 2024

Correspondent

Camille M. Miller Cozen O'Connor

1650 Market Street, Suite 2800,

Philadelphia PA 19103,

UNITED STATES OF AMERICA

KATAMARYN

Classification Information


Class [042]
Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific re Read More

Mark Details


Serial Number

2447216

Registered On

NA

Renewal On

NA

Mark Type

FIGURATIVE

Priority Claim (Convention Details)


Date

20 Dec 2023

Mark Type

US

Legal History


Show more

Status DateAction Taken
4th Sept 2024International Registration in Australia Protected After Adverse (No amendments) correspondence sent
3rd Sept 2024International Registration in Australia Protected After Adverse (No amendments) correspondence sent
3rd Sept 2024IP Right Registration Published
3rd Sept 2024Status change to Registered/Protected
28th Jun 2024Application Accepted correspondence sent
27th Jun 2024Application Accepted correspondence sent
27th Jun 2024IP Right has been Examined
27th Jun 2024IP Right Acceptance Published
27th Jun 2024Status change to Accepted
31st May 2024Examination Response Received